NCT06989931Completed
Intracranial Distal Access Catheter in Neurointerventional Therapy
A Clinical Study on the Safety and Effectiveness of Intracranial Distal Access Catheter in Neurointerventional Therapy
Source: ClinicalTrials.gov · Last updated 25 May 2025
Brief summary (registry, in English)
The study objective is to evaluate the safety and effectiveness of Intracranial Distal Access Catheter in neurointerventional therapy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 114 (actual)
- First submitted
- 15 Apr 2025
- Start date
- 7 Dec 2023
- Primary completion date
- 1 Mar 2024
- Lead sponsor
- MicroPort NeuroTech Co., Ltd.
- Diseases
- Stroke
- NCT number
- NCT06989931
What you commit to
- Study type: Observational
- Participants enrolled: 114
- From 7 Dec 2023 to the primary completion date, 1 Mar 2024
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Intracranial Distal Access Catheter is used during the interventional therapy of non-neurovascular diseases, such as peripheral vascular and coronary artery diseases.
Other
- Interventional procedure is performed with other distal catheters or devices with the same function before using Intracranial Distal Access Catheter.
- Ordinary guiding catheters can be used to establish access to complete the procedure without the use of Intracranial Distal Access Catheter.
Who the study is looking for
- Age = 18-80 years old.
- Patients with mechanical thrombectomy for acute ischemic stroke, treatment of intracranial aneurysms and other ischemic and hemorrhagic diseases, requiring the use of Intracranial Distal Access Catheter to complete the procedure (such as poor vascular access conditions, lesions located in secondary or higher branches of cerebral vessels, inability of conventional guiding catheters in place and providing effective support. Treatment with Flow-divert devices, covered stents, stent grafts, etc.)
- Patients agree to participate in the study and sign the informed consent form.（only prospective enrolled patients)
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jiangmen Xinhui District People's Hospital Coordinator of this site? Confirm its status | Jiangmen | China | Unknown status |
| The Affiliated Hospital of Yunnan University Coordinator of this site? Confirm its status | Kunming | China | Unknown status |
| The Sixth People's Hospital of Nantong Coordinator of this site? Confirm its status | Nantong | China | Unknown status |
| People's Hospital of Rizhao Coordinator of this site? Confirm its status | Rizhao | China | Unknown status |
| Xinxiang Central Hospital Coordinator of this site? Confirm its status | Xinxiang | China | Unknown status |
| Zhangzhou Municipal Hospital of Fujian Province Coordinator of this site? Confirm its status | Zhangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.